Here are three takeaways:
1. The article examined the cost-effectiveness of two-level cervical total disc replacement with the Mobi-C Cervical Disc as compared to anterior cervical discectomy and fusion based on five-year outcomes data.
2. The study found that for patients with two-level degenerative disc disease, TDR with Mobi-C seems to be a “highly cost-effective surgical modality compared with ACDF.”
3. Mobi-C is a cobalt chromium alloy and polyethylene mobile-bearing device that is designed as a bone-sparing, cervical intervertebral disc replacement for both one and two-level indications.
“We are excited to have this very important, long-term economic analysis of Mobi-C published, especially in such a prestigious journal as Neurosurgery. The principal finding of this study, that two-level Mobi-C appears to offer improved cost-effectiveness compared to ACDF (based on the 60-month outcomes), represents further evidence to support broader payer coverage for two-level cervical disc replacement and greater surgeon adoption of Mobi-C,” said Christophe Lavigne, president and CEO of LDR.
More articles on devices:
Spine surgery reimbursement: Key thoughts on coverage for new technology
Stryker buys Synergetics’ neuro portfolio on the heels of Sage acquisition: 5 key notes
NuVasive establishes new 52-week low: 4 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
